These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30447062)

  • 21. Plazomicin for the treatment of patients with complicated urinary tract infection.
    McCarthy MW
    Drugs Today (Barc); 2018 Sep; 54(9):513-518. PubMed ID: 30303492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical view of aminoglycoside antibiotics].
    Lüthy R
    Adv Clin Pharmacol; 1978; 15():119-26. PubMed ID: 676870
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New aminoglycoside desoxystreptamine-containing antibiotics].
    Gol'dberg LE
    Antibiotiki; 1976 Nov; 21(11):1033-50. PubMed ID: 65938
    [No Abstract]   [Full Text] [Related]  

  • 25. Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals.
    Tenover FC; Tickler I; Armstrong ES; Kubo A; Lopez S; Persing DH; Miller GH
    Int J Antimicrob Agents; 2011 Oct; 38(4):352-4. PubMed ID: 21820877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plazomicin: A New Aminoglycoside.
    Saravolatz LD; Stein GE
    Clin Infect Dis; 2020 Feb; 70(4):704-709. PubMed ID: 31328228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sisomicin: Bacteriological and clinical evaluation.
    Klastersky J; Hensgens C; Gérad M; Daneau D
    J Clin Pharmacol; 1975 Apr; 15(4 Pt 1):252-61. PubMed ID: 1092723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives.
    Terreni M; Taccani M; Pregnolato M
    Molecules; 2021 May; 26(9):. PubMed ID: 34063264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoglycoside therapy in infectious diseases.
    Poulikakos P; Falagas ME
    Expert Opin Pharmacother; 2013 Aug; 14(12):1585-97. PubMed ID: 23746121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
    Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging resistance to aminoglycosides in lactic acid bacteria of food origin-an impending menace.
    Jaimee G; Halami PM
    Appl Microbiol Biotechnol; 2016 Feb; 100(3):1137-1151. PubMed ID: 26631185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for plazomicin antibiotic action and resistance.
    Golkar T; Bassenden AV; Maiti K; Arya DP; Schmeing TM; Berghuis AM
    Commun Biol; 2021 Jun; 4(1):729. PubMed ID: 34117352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combating evolution with intelligent design: the neoglycoside ACHN-490.
    Armstrong ES; Miller GH
    Curr Opin Microbiol; 2010 Oct; 13(5):565-73. PubMed ID: 20932796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimizing use of aminoglycosides in the critically ill.
    Rea RS; Capitano B
    Semin Respir Crit Care Med; 2007 Dec; 28(6):596-603. PubMed ID: 18095223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic-induced diseases. Aminoglycoside-induced renal lesions].
    Gioannini P
    Minerva Med; 1978 Dec; 69(61):4215-25. PubMed ID: 366465
    [No Abstract]   [Full Text] [Related]  

  • 40. Developing a new antibiotic for extensively drug-resistant pathogens: the case of plazomicin.
    Theuretzbacher U; Paul M
    Clin Microbiol Infect; 2018 Dec; 24(12):1231-1233. PubMed ID: 30076976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.